Thyrocare Technologies appoints Dr Ramesh Kinha as COO

Attention Investors

Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000. | Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors." | KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary." | ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

- EQUITY
  EQUITY
  PRICE
  
  Gainers & Losers
  
  Advances & Declines
  
  New Highs & Lows
  
  Index Movers
  
  Only Buyers/Sellers
  
  Out/Under Performers
- NEWS
  CORPORATE ACTIONS
  
  Announcements
  
  Book Closure
  
  Board Meetings
  
  Bonus Issues
  
  Rights Issues
  
  De-Listed Shares
  
  Market Turnover
  
  Change of Name
  
  Split of Face Value
- OTHER MARKETS
  FII Investments
  
  MF Investments
  
  ADR Prices
  
  World Indices
  
  Forex
  
  CORPORATE INFO
- VOLUME
  VOLUME
  Value & Volume Toppers
  
  Unusual Volume
  
  Bulk & Block Deals
  
  Sector Watch
- ANALYSIS
  ANALYSIS
  52 Week High Low
  
  Live Indices
  
  Exchange Holidays
  
  Index Constituents
  
  Historical Returns
  
  Circuit Breakers
- IPO
  IPO
  
  Forthcoming Issues
  
  Open Issues
  
  Closed Issues
  
  New Listing
  
  Basis of Allotment
  
  Draft Prospectus
  
  New Issue Monitor
  
  Best Performers
  
  Know IPO's / FAQ's

09 January 2026 00:00:00

Adani Ports

1435.75

(-1.98%)

Asian Paints

2824.50

(1.36%)

Axis Bank

1271.95

(-1.16%)

Bajaj Finance

960.55

(-1.16%)

Bajaj Finserv

1992.70

(-0.80%)

Bharat Electro..

418.85

(0.77%)

Bharti Airtel

2027.30

(-1.89%)

Eternal

284.40

(0.32%)

HCL Technologi..

1662.30

(0.86%)

HDFC Bank

938.70

(-0.83%)

Hind. Unilever

2373.75

(-0.53%)

ICICI Bank

1403.55

(-2.22%)

Infosys

1614.75

(0.10%)

Interglobe Avi..

4844.70

(-1.22%)

ITC

337.10

(-1.11%)

Kotak Mah. Ban..

2126.75

(-0.29%)

Larsen & Toubr..

4026.75

(-0.03%)

M & M

3677.05

(-1.26%)

Maruti Suzuki

16501.00

(-0.98%)

NTPC

336.05

(-2.34%)

Power Grid Cor..

258.55

(-0.37%)

Reliance Indus..

1475.30

(0.34%)

SBI

1000.00

(0.22%)

Sun Pharma.Ind..

1729.95

(-1.79%)

Tata Steel

178.30

(-1.05%)

TCS

3208.00

(0.12%)

Tech Mahindra

1581.20

(0.23%)

Titan Company

4203.00

(-1.04%)

Trent

3975.80

(-0.32%)

UltraTech Cem.

11951.85

(-0.89%)

	Equity Analysis

	News Analysis

	Corporate Actions

	Other Market

	Company Profile

Share Holding Pattern

Your results on : Equity | News | Company-News

Thyrocare Technologies appoints Dr Ramesh Kinha as COO	Share Back
(18 Dec 2025)
Dr. Ramesh Kinha is a healthcare and diagnostics professional with over 17 years of experience. Before joining the company, he was Group Director – Laboratory Services at Vijaya Diagnostic Centre and has held leadership roles at Apollo Health & Lifestyle, Medall Healthcare, Metropolis Healthcare, and SRL. He holds an MBBS and an MD (Pathology), has completed senior management programs from IIM Nagpur and ISB, and is an NABL Assessor. Thyrocare Technologies is India's first and foremost advanced fully automated laboratory chain with a strong presence PAN India. The company focuses on providing quality and affordable diagnostic services to laboratories and hospitals. Thyrocare has a quarterly active franchise count of more than 10,000 and has processed over 53.3 million diagnostic and screening investigations in Q2 FY26. The company reported an 82% jump in consolidated net profit to Rs 47.90 crore on a 22% rise in revenue from operations to Rs 216.53 crore in Q2 FY26 over Q2 FY25. Shares of Thyrocare Technologies shed 0.23% to Rs 441.30 on the BSE.
Top